ArticleColloids and surfaces. B, Biointerfaces2019

Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.

Sushant Lakkadwala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.